Eisai Completes Rolling Submission to US FDA for LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status

Lockheed Martin (LMT) secured a $1.21B U.S. Army contract, boosting its defense sector standing. The company offers a 2.62% dividend yield, a 50% payout ratio, and 5.4% 3-year dividend growth. Its GF Value™ suggests a 6.0% undervaluation, with a GF Score™ of 80/100. Insider activity shows net selling, while institutional confidence remains strong.

Santos has signed two separate LNG agreements, one with POSCO Steel and another with Western LNG. The deals involve the supply of LNG from Santos' Gladstone LNG project in Australia. The agreements are expected to strengthen Santos' position in the LNG market.

Sempra Infrastructure, a Sempra (SRE) subsidiary, signed a 20-year LNG supply deal with Petrobras, supplying 0.8 Mtpa from its Port Arthur LNG Phase 2 project. The project, under construction, aims to expand liquefaction capacity to 26 Mtpa by 2031. Sempra Infrastructure highlights the strategic role in global energy markets.

Sempra Infrastructure (SRE) signed a 20-year LNG supply deal with Petrobras for 0.8 million tonnes per year. The LNG will come from Sempra's Port Arthur LNG Phase 2 project in Texas, expected to start operations in 2030-2031. This is Sempra's first South American customer.

Wood secured a $200M, five-year contract with ExxonMobil PNG to provide construction services for the PNG LNG Project. The deal covers brownfield activities at multiple sites and involves over 200 Wood personnel.

Abbott Labs will pay $385M to settle legal claims related to a 2022 contamination inquiry at its Sturgis, Michigan plant, which caused a recall and supply shortages. The settlement does not admit fault. Abbott maintains no unopened formula tested positive for Cronobacter. The plant reopened in June 2022 after a closure. The Biden administration took steps to alleviate the shortage.